A study has revealed the role of a protein which enables human cytomegalovirus to spread, the number one cause of congenital birth defects in the world.
List view / Grid view
Filter the results
From the world’s flagship neutron science facility, Institut Laue-Langevin (ILL), Matthew Blakeley shares insights into how they are harnessing the power of neutrons to aid their search for new cancer treatments.
Redundancies have been discovered in the biochemical signalling pathways of immune cells which could impact cancer immunotherapy.
A new study has identified antibodies that may hold the key to creating the first effective vaccine against malaria infection in the blood.
New study finds a combination of antibodies that can prepare mice to accept stem cells from an immunologically mismatched donor.
Scientists from LifeArc, an independent medical research charity in the UK, explain how they’re using the latest imaging technologies to progress drug discovery campaigns and identify the most promising candidates for antibody-based therapies.
Conventional methods for radiolabelling proteins are time consuming and difficult to automate. In this article, Jason P. Holland discusses how combining photochemistry with radiochemistry enables development of radiolabelled proteins far more quickly and easily – literally in a flash of light.
An international team of researchers has proven that targeting a specific area of the flu virus protects humans.
Scientists have discovered an unexpected weakness in the influenza virus protein.
16 May 2019 | By
Researchers say they have affirmed inconsistencies in the use of a common laboratory procedure called immunohistochemical staining.
By the 1890s William B. Coley had injected streptococcal organisms in patients with solid tumours (“Coley’s Toxins”) to activate the immune system. Coley (1862-1936) was an American bone surgeon and pioneer of cancer immunotherapy. He was convinced that post-surgical infections had helped patients to recover better from their cancer by…
Scientists have detailed the role of a key controlling factor in the transformation of B-cells into antibody-secreting cells.
Researchers from the University of Zurich have created a new method for radiolabelling antibodies using UV light - with proteins being ready-to-use for cancer imaging or therapy in less than 15 minutes.
Novel therapy uses antibodies cloned from patients who have recovered from an infection caused by the fungus Candida…